John Giacomini, MD

Publication Details

  • Statin therapy in heart failure.

    Pham M, Oka RK, Giacomini JC. Curr Opin Lipidol. 2005; 16 (6): 630-4

    The 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors, or statins, have been shown to reduce cardiovascular morbidity and mortality among a wide spectrum of patients with established atherosclerotic vascular disease. Mounting experimental and clinical evidence also suggest a potential benefit as well as theoretical harm of statin therapy in patients with heart failure.

    PubMedID: 16276240

Stanford Medicine Resources:

Footer Links: